PINL:GRPOF - Post by User
Post by
Irievibes13on Feb 04, 2018 12:39pm
254 Views
Post# 27499264
Best part
Best partBtw this part really stuck out to me. "With the expertise of Sant Cannabis, we expect to demonstrate the clinical benefits of PPP001 on the quality of life of advanced cancer patients. It's important to note that our clinical program will also address the potential of PPP001 to reduce the reliance on opioids for management of severe pain. We expect that, once it is approved as a drug under prescription, PPP001 will be included over time ahead of opioids treatment for those patients with terminal cancer pain......so they will be running a side trial on reducing opioid use in cancer patients, which in turn info could be used as an alternative to opioid addiction..huge potential here...GO TETRA!